Características maternas y resultados perinatales asociados con el cribado de diabetes gestacional

  • Clarice dos Santos Mottecy Graduate Program in Health Promotion, University of Santa Cruz do Sul (UNISC), Santa Cruz do Sul-RS, Brazil.
  • Patrí­cia Molz Graduate Program in Health Promotion, University of Santa Cruz do Sul (UNISC), Santa Cruz do Sul-RS, Brazil; Experimental Nutrition Laboratory, University of Santa Cruz do Sul (UNISC), Santa Cruz do Sul-RS, Brazil; Graduate Program in Biomedical Sciences, Federal University of Health Sciences of Porto Alegre-RS (UFCSPA), Brazil.
  • Raquel Montagner Rossi Faculty of Medicine, Federal University of Santa Maria (UFSM), Santa Maria-RS, Brazil.
  • Itamar dos Santos Riesgo Department of Obstetrics and Gynaecology, Federal University of Santa Maria (UFSM), Santa Maria-RS, Brazil.
  • João Francisco Piovezan Ramos Federal University of Santa Maria (UFSM), Santa Maria-RS, Brazil.
  • Daniel Prá Graduate Program in Health Promotion, University of Santa Cruz do Sul (UNISC), Santa Cruz do Sul-RS, Brazil; Experimental Nutrition Laboratory, University of Santa Cruz do Sul (UNISC), Santa Cruz do Sul-RS, Brazil.
  • Silvia Isabel Rech Franke Graduate Program in Health Promotion, University of Santa Cruz do Sul (UNISC), Santa Cruz do Sul-RS, Brazil. 2 - Experimental Nutrition Laboratory, University of Santa Cruz do Sul (UNISC), Santa Cruz do Sul-RS, Brazil.
Palabras clave: Diabetes gestacional, Factores de riesgo, Atención prenatal, Salud maternoinfantil

Resumen

Introducción y objetivo: La Diabetes Gestacional (DG) puede conllevar varios resultados adversos para la madre y el feto. Por lo tanto, este estudio tiene como objetivo describir los factores de riesgo y los resultados en mujeres embarazadas asociados con el cribado de DG.Materiales y métodos: Este estudio retrospectivo se realizó con 283 mujeres embarazadas en un Hospital Universitario del Sur de Brasil. Los datos de detección de GD, incluidas las pruebas de glucosa en sangre en ayunas y la prueba de tolerancia oral a la glucosa (OGTT), se recopilaron de la tarjeta de la mujer embarazada. También se recopiló información relacionada con los resultados maternos y perinatales, así como con el estatus socioeconómico de las mujeres embarazadas.Resultados: La tasa de detección positiva de DG en puérperas fue del 25,2%, considerando únicamente la glucemia en ayunas. Sin embargo, aumentó al 86,4% cuando se consideraron la glucemia en ayunas y la presencia de factores de riesgo. No hubo asociación significativa entre la detección positiva de DG y los resultados maternos y perinatales, ni con el nivel socioeconómico. Sin embargo, los niveles de glucosa en sangre en ayunas ≥85 mg/dL se asociaron con un mayor riesgo de cesárea y otras complicaciones fetales, como hipoglucemia, peso inadecuado del recién nacido y edad gestacional de menos de 37 semanas al nacer. Además, la detección de DG se asoció significativamente con el resultado de la preeclampsia. Conclusión: Los resultados del estudio indican que la detección positiva de DG se asocia con un mayor riesgo de parto por cesárea, preeclampsia y otras complicaciones fetales.

Citas

-Babu, G.R.; Tejaswi, B.; Kalavathi, M.; Vatsala, G.M.; Murthy, G.V.S.; Kinra, S.; Neelon, S.E.B. Assessment of screening practices for gestational hyperglycaemia in public health facilities: a descriptive study in Bangalore, India. Journal of Public Health Research. Vol. 4. Num. 1. 2015. p. jphr-2015.

-Battaglia, F.C.; Lubchenco, L.O.A practical classification of newborn infants by weight and gestational age. The Journal of Pediatrics. Vol. 71. Num. 2. 1967. p.159-163.

-Brazil. Ministry of Health. Vigitel Brasil 2019: vigilance of risk factors and protection against chronic diseases through phone encounters: estimations on frequency and sociodemographic distribution of risk factors and protection against chronic diseases in the capitals of the 26 states and the Federal District in 2019. Brasília: Ministry of Health. 2020.

-Brazil. Ministry of Heath. Atenção ao pré-natal de baixo risco. Brasília: Ministry of Health. 2012.

-Brazilian Association of Research Companies. Brazilian Sociaty of Research Companies. Brasília: ABEP. 2013. www.abep.org/new/criterioBrasil.aspx.

-Brazilian Diabetes Society. Brazilian Diabetes Society Guideline 2019-2020. São Paulo. Clannad. 2019.

-Brazilian Society of Pediatrics. Guidelines of the Brazilian Society of Pediatrics. Neonatal hypoglycemia. Rio de Janeiro: Brazilian Society of Pediatrics. 2014.

-Capurro, H., Konichezky, S.; Fonseca, D.; Caldeyro-Barcia, R. A simplified method for diagnosis of gestational age in the newborn infant. The Journal of pediatrics. Vol. 93. Num. 1. 1978. p. 120-122.

-Detsch, J.C.M.; Almeida, A.C.R.D.; Bortolini, L.G.C.; Nascimento, D.J.; Junior, F.C.O.; Réa, R.R. Markers of diagnosis and treatment in 924 pregnancies with gestational diabetes mellitus. The Archives of Endocrinology and Metabolism. Vol. 55. Num. 6. 2011. p.389-398.

-Farahvar, S.; Walfisch, A.; Sheiner; E. Gestational diabetes risk factors and long-term consequences for both mother and offspring: a literature review. Expert Review of Endocrinology & Metabolism. Vol. 14. Num. 1. 2019. p. 63-74.

-Farrar, D.; Simmonds, M.; Bryant, M.; Lawlor, D.A.; Dunne, F.; Tuffnell, D.; Sheldon, T.A. Risk factor screening to identify women requiring oral glucose tolerance testing to diagnose gestational diabetes: a systematic review and meta-analysis and analysis of two pregnancy cohorts. PloS One. Vol. 12. Num. 4. 2017. p. e0175288.

-Hu, F. B. Globalization of diabetes: the role of diet, lifestyle, and genes. Diabetes Care. Vol. 34. Num. 6. 2011. p. 1249-57.

-Institute of Medicine. Weight Gain During Pregnancy: Reexamining the Guidelines. Washington: National Academies Press. 2009.

-International Diabetes Federation. IDF Diabetes Atlas. 9th ed. Brussels: IDF. 2019.

-Logakodie, S.; Azahadi, O.; Fuziah, P.; Norizzati, B.I.B.; Tan, S.F.; Zienna, Z.Z.R.; Norliza, M.; Noraini, J.; Hazlin, M.; Noraliza, M. Z.; Sazidah, M. K. Gestational diabetes mellitus: The prevalence, associated factors and foeto-maternal outcome of women attending antenatal care. Malaysian Family Physician: The Official Journal of the Academy of Family Physicians of Malaysia. Vol. 12. Num. 2. 2017. p. 9.

-Mahalakshmi, M.M.; Bhavadharini, B.; Maheswari, K.; Kalaiyarasi, G.; Anjana, R.M.; Ranjit, U.; Mohan, V.; Joseph, K.; Rekha, K.; Nallaperumal, S.; Malanda, B. Comparison of maternal and fetal outcomes among Asian Indian pregnant women with or without gestational diabetes mellitus: a situational analysis study (WINGS-3). Indian Journal of Endocrinology and Metabolism. Vol. 20. Num. 4. 2016. p. 491.

-Massucatti, L.A.; Pereira, R.A.; Maioli, T.U. The prevalence of gestational diabetes in basic health units. Revista de Enfermagem e Atenção à Saúde. Vol. 1. Num. 01. 2012.

-Menezes, M.G.B.; Dias, D.F.S. A humanização do cuidado no pré-parto e parto. SynThesis Revista Digital FAPAM. Vol. 3. Num. 3. 2012. p. 24-36.

-Ng, R.; Sutradhar, R.; Yao, Z.; Wodchis, W.P.; Rosella, L. C. Smoking, drinking, diet and physical activity-modifiable lifestyle risk factors and their associations with age to first chronic disease. International Journal of Epidemiology. Vol. 49. Num. 1. 2020. p. 113-130.

-Pan-American Health Organization. Ministry of Health. Brazilian Federation of the Gynecology and Obstetrics Associations. Brazilian Society of Diabetes. Screening and diagnosis of gestational diabetes mellitus in Brazil. Brasília. OPAS. 2017.

-Sacks, D.A.; Hadden, D.R.; Maresh, M.; Deerochanawong, C.; Dyer, A.R.; Metzger, B.E.; Lowe, L.P.; Coustan, D.R.; Hod, M.; Oats, J.J.; Persson, B. Frequency of gestational diabetes mellitus at collaborating centers based on IADPSG consensus panel-recommended criteria: the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. Diabetes Care. Vol. 35. Num. 3. 2012. p. 526-528.

-Santos, P.A.; Madi, J.M.; Silva, E.R.; Vergani, D.D.; Araújo, B.F.; Garcia, R.M. Gestational diabetes in the population served by Brazilian public health care. Prevalence and risk factors. RBGO Gynecology and Obstetrics. Vol. 42. 2020. p. 12-8.

-Simon, C.Y.; Marques, M.C.; Farhat, H.L. First trimester fasting glycemia and risk factors of pregnant women diagnosed with gestational diabetes mellitus. RBGO Gynecology and Obstetrics. Vol. 35. 2013. p. 511-5.

-Spong, C.Y. Defining “term” pregnancy: recommendations from the Defining “Term” Pregnancy Workgroup. Jama. Vol. 309. Num. 23. p. 2445-6.

-World Health Organization. Global Report on Diabetes. Geneva: WHO. 2016.

-Yogev, Y.; Metzger, B.E.; Hod, M. April. Establishing diagnosis of gestational diabetes mellitus: Impact of the hyperglycemia and adverse pregnancy outcome study. Seminars in Fetal and Neonatal Medicine. Vol. 14. Num. 2, p. 94-100. 2009.

-Zhou, B.; Lu, Y.; Hajifathalian, K.; Bentham, J.; Di Cesare, M.; Danaei, G.; Bixby, H.; Cowan, M. J.; Ali, M.K.; Taddei, C.; Lo, W.C. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 44 million participants. The Lancet. Vol. 387. Num. 10027. 2016. p. 1513-1530.

Publicado
2024-08-06
Cómo citar
Mottecy, C. dos S., Molz, P., Rossi, R. M., Riesgo, I. dos S., Ramos, J. F. P., Prá, D., & Franke, S. I. R. (2024). Características maternas y resultados perinatales asociados con el cribado de diabetes gestacional. Revista Brasileña De Obesidad, Nutrición Y Pérdida De Peso, 18(115), 711-719. Recuperado a partir de https://www.rbone.com.br/index.php/rbone/article/view/2459
Sección
Artículos Científicos - Original